Home Newsfeeds Cowen & Co. Downgrades Lyft to Market Perform

Cowen & Co. Downgrades Lyft to Market Perform

Cowen & Co. analyst John Blackledge downgrades Lyft (NASDAQ:LYFT) from Outperform to Market Perform.

byBenzinga Newsdesk

November 22, 2022

1 minute read

Cowen & Co. analyst John Blackledge downgrades Lyft (NASDAQ:LYFT) from Outperform to Market Perform.

Apple Is A ‘Top Stock Pick For 2024,’ Analyst Says: 4 Catalysts To Look For In Next Earnings Report

By Surbhi Jain

April 23, 8:48 AM

Apple is expected to report $90.83 billion in revenue on May 2 after the market closes. AI advancements are among the catalysts to watch.

AAPL

Why Should Cannabis Investors Pay Attention To Germany? These Stocks Will Benefit From Imminent Legalization

By Jelena Martinovic

August 22, 11:03 AM

With US federal legalization stalled and its near-term outcome uncertain, cannabis stocks are taking a hit. Cantor Fitzgerald's analyst Pablo Zuanic advised investors to turn their interest to Germany, or at least for now.

ACB

Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today?

By Vandana Singh

January 24, 3:08 PM

Evaxion Biotech revolutionizes cancer vaccine development, targeting AI-identified ERVs. Preclinical activities underway; Proof-of-Concept data expected by 2H 2024.

EVAX

Here’s How Much $100 Invested In Regeneron Pharmaceuticals 10 Years Ago Would Be Worth Today

By Benzinga Insights

June 3, 2:00 PM

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 10 years by 1.96% on an annualized basis…

REGN

Cowen & Co. Downgrades Lyft to Market Perform

Related Posts

Apple Is A ‘Top Stock Pick For 2024,’ Analyst Says: 4 Catalysts To Look For In Next Earnings Report

Why Should Cannabis Investors Pay Attention To Germany? These Stocks Will Benefit From Imminent Legalization

Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today?

Here’s How Much $100 Invested In Regeneron Pharmaceuticals 10 Years Ago Would Be Worth Today